Polar Capital’s Ascendis Pharma A/S ASND Stock Holding History

Polar Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$11.8M	Buy	76,643 +25,000	+48%	+$3.59M	0.09%	171
2020 Q2	$7.64M	Buy	51,643 +20,200	+64%	+$2.77M	0.07%	190
2020 Q1	$3.54M	Sell	31,443 -18,557	-37%	-$2.41M	0.04%	223
2019 Q4	$6.96M	Buy	50,000 +25,000	+100%	+$2.78M	0.06%	218
2019 Q3	$2.41M	Hold	25,000	–	–	0.02%	253
2019 Q2	$2.88M	Buy	+25,000	New	+$2.99M	0.03%	246
2018 Q4	–	Sell	-50,000	Closed	-$3.54M	–	262
2018 Q3	$3.54M	Hold	50,000	–	–	0.03%	229
2018 Q2	$3.33K	Hold	50,000	–	–	0.02%	233
2018 Q1	$3.27M	Sell	50,000 -25,000	-33%	-$1.41M	0.03%	231
2017 Q4	$3M	Buy	+75,000	New	+$2.73M	0.03%	225

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Polar Capital's ASND Position: Q3 2020 in Review

Polar Capital increased its Ascendis Pharma A/S (ASND) stake by 48% in Q3 2020, buying an estimated $3.59M and bringing the position to 76,643 shares worth $11.8M. The position accounts for 0.09% of the portfolio, ranked #171.

Polar Capital first reported a position in ASND in Q4 2017 and has held it in 10 quarters since. 152 funds tracked by Wall St. Rank hold ASND as of Q3 2020.

Polar Capital held 76,643 shares of Ascendis Pharma A/S worth $11.8M as of Q3 2020.
Polar Capital bought 25,000 Ascendis Pharma A/S shares in Q3 2020, an estimated $3.59M.
Ascendis Pharma A/S made up 0.09% of Polar Capital's portfolio in Q3 2020, its #171 holding.
Polar Capital first reported a position in Ascendis Pharma A/S in Q4 2017 and has held it in 10 quarters since.
152 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.